Healthy Clinical Trial
Official title:
Metabolic Response to Variations in Dietary Glycemic Index
Verified date | April 2024 |
Source | Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this study is to compare metabolic response to variations in dietary glycemic index in healthy participants. The main questions it aims to answer are: • What are the metabolic hunger and food intake responses to different levels of glycemic index on the background of otherwise constant macronutrient composition? Participants will come to the lab after an overnight fast and body composition will be tested by bio-impedance analysis and magnetic resonance imaging. They will then be randomized to eat one of three standardized breakfasts varying in the glycemic index. Circulating glucose levels will be monitored using a continuous glucose monitor and blood samples will be collected to measure metabolic and hormone factors in the serum. Participants will also rate their hunger at 0, 30, 60, 120, 180, 240 and 300 minutes. After 5 hours they will eat a free choice meal from a standardized selection buffet (test meal).
Status | Recruiting |
Enrollment | 120 |
Est. completion date | December 1, 2024 |
Est. primary completion date | December 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - Healthy adults (both men and women) - 18-40 years old - 18.5 = BMI (body mass index)<24 kg/m2 Exclusion Criteria: - Those who have undergone surgery in the past 6 months. - People are requiring long-term medication. - People have metabolic diseases, like diabetes, hypoglycemia, gout, osteoporosis, et al. - Those who have recently lost weight for various medical reasons (e.g. cancer, etc.). - People are losing weight by tablets. - People are suffering from infectious diseases (e.g. HIV, etc.) - People have blood phobia, pathological hypo or hyper tension. - People with impaired glucose tolerance. - Pregnant and lactation women. - Those who are afflicted with claustrophobia. |
Country | Name | City | State |
---|---|---|---|
China | Shenzhen Institute of Advanced Technology | Shenzhen | Guangdong |
Lead Sponsor | Collaborator |
---|---|
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | fat mass tested by bioelectrical impedance analysis | Fat mass will be tested by bioelectrical impedance analysis(Tanita, MC-980) in kg. | pre measurement | |
Other | fat mass tested by magnetic resonance imaging | Fat mass will be tested by magnetic resonance imaging(Shanghai united imaging, uMR790) in %. | pre measurement | |
Other | fat free mass tested by bioelectrical impedance analysis | Fat free mass will be tested by bioelectrical impedance analysis(Tanita, MC-980) in kg. | pre measurement | |
Other | fat free mass tested by magnetic resonance imaging | Fat free mass will be tested by magnetic resonance imaging(Shanghai united imaging, uMR790) in %. | pre measurement | |
Other | sex difference in energy intake | The impact of sex on energy intake will be explored by correlation analysis. | pre measurement | |
Other | sex difference in circulating hormones | The impact of sex on circulating hormones will be explored by correlation analysis. | pre measurement | |
Other | sex difference in postprandial glucose | The impact of sex on postprandial glucose will be explored by correlation analysis. | pre measurement | |
Other | sex difference in self reported hunger | The impact of sex on self reported hunger will be explored by correlation analysis. | pre measurement | |
Other | sex difference in circulating metabolic fuels | The impact of sex on circulating metabolic fuels will be explored by correlation analysis. | pre measurement | |
Other | sex difference in fat mass | The impact of sex on fat mass will be explored by correlation analysis. | pre measurement | |
Other | sex difference in fat free mass | The impact of sex on fat free mass will be explored by correlation analysis. | pre measurement | |
Primary | Change in energy intake of test meal between day 0 and day 1 | The food intake will be assessed objectively by use of a feeding table. The test meal will be provided as lunch, and food types available on the table include staples, vegetables, mushrooms, meat, soy products, desserts, beverages and water. All types of food are unlimited. Food consumption will be recorded continuously by balances concealed under each food dish. The food energy density for each food will be measured by bomb calorimetry in kJ/g, and energy intake will be calculated as the product of the grams of each food eaten multiplied by the respective energy density and then summed, as kJ.
This test meal intake is measured on day 0 and then a repeat test meal measure is made under identical conditions on day 1. On day 1 an intervention meal is also consumed five hours before the test meal is consumed. On day 0 no such meal is consumed. The outcome measure is the change in food intake (kJ) between day 0 and day 1 reflecting the impact of the intervention meal. |
Change in intake between day 0 and day 1 | |
Secondary | circulating hormones | Nurses will collect the blood samples on day 1. Levels of circulating hormones (insulin, leptin, glycogen,etc) in the serum will be measured by ELISA(Bio Tek, Synergy4) in mmol/L. | fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes. | |
Secondary | postprandial glucose | Standardized meal with different levels of glycemic index( low level: = 55, moderate level: 55 < GI = 70, high level: > 70) will be provided as breakfast on day 1. Independent of the GI, the energy supply ratio of macronutrients carbohydrate, protein and fat will be fixed at 60 %, 20 % and 20 % respectively. Glucose concentration after the standardized meal will be recorded by the continuous glucose monitoring system(Medtronic) in mmol/L during 5 hours. | fasting glucose and postprandial glucose for 5 hours | |
Secondary | self reported hunger | Self reported hunger will be tested by rating scale question. | fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes. | |
Secondary | levels of circulating metabolic fuels | Nurses will collect the blood samples on day 1. Circulating lactate, free-fatty acids, triglycerides etc in mmol/L will be measured by ELISA(Bio Tek, Synergy4). | fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |